Showing results (1651-1660 of 1,948) with videos related to
Sort By:
Pageof 195
Annals of Neurology|February 22, 2018
Mutations in SCN3A cause early infantile epileptic encephalopathyTariq Zaman, Ingo Helbig, Ivana Babić Božović, et al.The Journal of Clinical Investigation|May 16, 2023
Viral vector-mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndromeSaja Fadila, Bertrand Beucher, Iria González Dopeso-Reyes, et al.American Journal of Clinical Oncology|October 20, 2000
Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group TrialP A Burch, C Ghosh, G Schroeder, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumorsA A Adjei, C Erlichman, J A Sloan, et al.Medical and Pediatric Oncology|January 1, 1989
Treatment of acute nonlymphocytic leukemia in the elderly with intermediate high-dose cytosine arabinosideL Letendre, R D Niedringhaus, T M Therneau, et al.The Oncologist|December 15, 2010
A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603)Eileen M O'Reilly, Donna Niedzwiecki, Margaret Hall, et al.The Journal of Urology|March 1, 1994
Transdermal clonidine for ameliorating post-orchiectomy hot flashesC L Loprinzi, R M Goldberg, J R O'Fallon, et al.Cancer|September 1, 1990
A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancerH E Windschitl, M J O'Connell, H S Wieand, et al.Nature Communications|April 5, 2016
Ancient human sialic acid variant restricts an emerging zoonotic malaria parasiteSelasi Dankwa, Caeul Lim, Amy K Bei, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741Hanna K Sanoff, Daniel J Sargent, Megan E Campbell, et al.Pageof 195